Enveric Biosciences, Inc.
ENVB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,575 | -$17,292 | -$18,471 | -$48,977 |
| Dep. & Amort. | $337 | $408 | $435 | $682 |
| Deferred Tax | $0 | $0 | -$1,504 | -$7,455 |
| Stock-Based Comp. | $1,562 | $2,150 | $2,621 | $12,597 |
| Change in WC | -$423 | -$175 | -$218 | $1,185 |
| Other Non-Cash | $372 | $814 | -$9 | $30,510 |
| Operating Cash Flow | -$7,726 | -$14,094 | -$17,147 | -$11,458 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$5 | -$584 | -$865 |
| Net Acquisitions | $0 | $0 | $958 | $3,055 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $17 | -$958 | -$1 |
| Investing Cash Flow | $0 | $12 | -$584 | $2,191 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,290 | $0 | $17,222 | $21,614 |
| Stock Repurch. | $1,084 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,300 | -$1,343 | $958 | $3,285 |
| Financing Cash Flow | $7,674 | -$1,343 | $18,180 | $24,900 |
| Forex Effect | $5 | -$10 | -$81 | $145 |
| Net Chg. in Cash | -$47 | -$15,436 | $368 | $15,778 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,288 | $17,724 | $17,356 | $1,578 |
| End Cash | $2,241 | $2,288 | $17,724 | $17,356 |
| Free Cash Flow | -$7,726 | -$14,100 | -$17,731 | -$12,322 |